Printed From BioPortfolio.com
Biomarkers may help identify patients at increased risk of neurotoxicity from CD19 CAR T-cell therapy
05:05 EDT 12 Oct 2017 | ecancermedicalscience
New potential biomarkers and a novel algorithm could help identify patients at increased risk of suffering from severe neurotoxicity after receiving CD19 CAR T-cell therapy. The study extensively characterised common and occasionally fatal side effects...
Original Article: Biomarkers may help identify patients at increased risk of neurotoxicity from CD19 CAR T-cell therapy
